Oziębło, S.; Mizera, J.; Górska, A.; Krzyziński, M.; Karpiński, P.; Markiewicz, A.; Sąsiadek, M.M.; Romanowska-Dixon, B.; Biecek, P.; Hoang, M.P.;
et al. Co-Targeting of DTYMK and PARP1 as a Potential Therapeutic Approach in Uveal Melanoma. Cells 2024, 13, 1348.
https://doi.org/10.3390/cells13161348
AMA Style
Oziębło S, Mizera J, Górska A, Krzyziński M, Karpiński P, Markiewicz A, Sąsiadek MM, Romanowska-Dixon B, Biecek P, Hoang MP,
et al. Co-Targeting of DTYMK and PARP1 as a Potential Therapeutic Approach in Uveal Melanoma. Cells. 2024; 13(16):1348.
https://doi.org/10.3390/cells13161348
Chicago/Turabian Style
Oziębło, Sylwia, Jakub Mizera, Agata Górska, Mateusz Krzyziński, Paweł Karpiński, Anna Markiewicz, Maria Małgorzata Sąsiadek, Bożena Romanowska-Dixon, Przemysław Biecek, Mai P. Hoang,
and et al. 2024. "Co-Targeting of DTYMK and PARP1 as a Potential Therapeutic Approach in Uveal Melanoma" Cells 13, no. 16: 1348.
https://doi.org/10.3390/cells13161348
APA Style
Oziębło, S., Mizera, J., Górska, A., Krzyziński, M., Karpiński, P., Markiewicz, A., Sąsiadek, M. M., Romanowska-Dixon, B., Biecek, P., Hoang, M. P., Mazur, A. J., & Donizy, P.
(2024). Co-Targeting of DTYMK and PARP1 as a Potential Therapeutic Approach in Uveal Melanoma. Cells, 13(16), 1348.
https://doi.org/10.3390/cells13161348